Of these genetic changes, K-Ras and p53 are the most prominent mutations associated with the urethane-induced model [ 61, 110].
The DNA was added to individual allele-specific PCR reactions targeting seven mutations in codons 12 and 13 of KRAS, seven mutations in exons 9 and 20 of the PI3 kinase gene, the T>A transversion in exon 15 of the BRAF gene and the most prominent mutations, deletions and insertions in exons 18 21 of the EGFR gene.
We established sensitive (5 10% mutant allele), reproducible and linear pyrosequencing assays for the most prominent mutation hotspots in EGFR and KRAS (Supplementary Fig. S2, S3, S4, S5, S6, S7, S8, S9, S10).
The missense mutation R273H belongs to the most prominent mutation hot-spots in the TP53 gene and alters the target DNA sequence [ 37].
Since the deletion in the scaffold 15 is the most prominent mutation identified in Rut-C30 we wanted to study its effect more thoroughly, namely whether the deletion has an effect on hydrolytic enzyme production.
This conclusion was further supported by analysis of mutation spectra after removal of CpG dinucleotides, the most prominent mutational hotspots in the human genome [ 24, 25].
Although increased kinase activity was consistently shown for the most prominent G2019S mutation, data for other mutations are contradictory.
The most prominent missense mutation detected in TPI deficiency patients occurs at codon 104 in the TPI gene encoding aspartic acid instead of glutamic acid within the enzyme (Glu104Asp variant) and accounts for approximately 80% of mutant alleles within Northern European kindreds with clinical TPI deficiency [14], [15].
The most prominent pathogenic LRRK2 mutation (G2019S), located within the kinase domain, has been consistently shown to enhance kinase activity in vitro (4– 7), suggesting that it may display a dominant, gain-of-function phenotype.
Several the least connected genes are mentioned in the literature in association with ovarian cancer: The most prominent is TP3 (P53) which mutations lead to various types of cancer as reported in Schuijer and Berns [ 20].
Mutations were most prominent in the DNA binding domain, encoded by exons 5 8, and only about five percent of the mutations were observed in exon 4 and exon 11.
